Zebrafish models for the functional genomics of neurogenetic disorders

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 3, 2011, Pages 335-345

  Kabashi, Edor ^a,b   Brustein, Edna ^b   Champagne, Nathalie ^a,b   Drapeau, Pierre ^b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Animal models; Genomics; Human diseases; Human genetics; Neurodegenerative disorders; Neurodevelopmental diseases; Neurogenetic diseases; Trangenic animals; Zebrafish

Indexed keywords

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ATAXIA; AUTISM; BRAIN; BRAIN DISEASE; CHEMICAL GENETICS; CYTOLOGY; DEMENTIA; DEVELOPMENTAL DISORDER; EPILEPSY; FISH GENETICS; FUNCTIONAL GENOMICS; GENE FUNCTION; GENE LOSS; GENE MUTATION; GENE SILENCING; GENETIC DISORDER; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUNTINGTON CHOREA; MENTAL DEFICIENCY; MUSCLE ATROPHY; NERVE CELL DEGENERATION; NEUROGENETIC DISORDER; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SPINAL CORD; SPINAL CORD DISEASE; SPINAL MUSCULAR ATROPHY; ZEBRA FISH;

ANIMALIA; DANIO RERIO;

EID: 78751704366     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.09.011     Document Type: Review

References (127)

1. Volff J.N. Genome evolution and biodiversity in teleost fish. Heredity 2005, 94:280-294.
2. Nasevicius A., Ekker S.C. Effective targeted gene 'knockdown' in zebrafish. Nat. Genet. 2000, 26:216-220.
3. Moulton J.D., Yan Y.L. Using morpholinos to control gene expression. Curr. Protoc. Mol. Biol. 2008, Chapter 26, Unit 26 28.
4. Turner D.L., Weintraub H. Expression of achaete-scute homolog 3 in Xenopus embryos converts ectodermal cells to a neural fate. Genes Dev. 1994, 8:1434-1447.
5. Ro H., Soun K., Kim E.J., Rhee M. Novel vector systems optimized for injecting in vitro-synthesized mRNA into zebrafish embryos. Mol. Cells 2004, 17:373-376.
6. Best J.D., Alderton W.K. Zebrafish: an in vivo model for the study of neurological diseases. Neuropsychiatr. Dis. Treat. 2008, 4:567-576.
7. Ingham P.W. The power of the zebrafish for disease analysis. Hum. Mol. Genet. 2009, 18:R107-R112.
8. Leimer U., Lun K., Romig H., Walter J., Grunberg J., Brand M., Haass C. Zebrafish (Danio rerio) presenilin promotes aberrant amyloid beta-peptide production and requires a critical aspartate residue for its function in amyloidogenesis. Biochemistry 1999, 38:13602-13609.
9. Nornes S., Newman M., Verdile G., Wells S., Stoick-Cooper C.L., Tucker B., Frederich-Sleptsova I., Martins R., Lardelli M. Interference with splicing of presenilin transcripts has potent dominant negative effects on presenilin activity. Hum. Mol. Genet. 2008, 17:402-412.
10. Newman M., Tucker B., Nornes S., Ward A., Lardelli M. Altering presenilin gene activity in zebrafish embryos causes changes in expression of genes with potential involvement in Alzheimer's disease pathogenesis. J. Alzheimers Dis. 2009, 16:133-147.
11. Groth C., Nornes S., McCarty R., Tamme R., Lardelli M. Identification of a second presenilin gene in zebrafish with similarity to the human Alzheimer's disease gene presenilin2. Dev. Genes Evol. 2002, 212:486-490.
12. Nornes S., Groth C., Camp E., Ey P., Lardelli M. Developmental control of presenilin1 expression, endoproteolysis, and interaction in zebrafish embryos. Exp. Cell Res. 2003, 289:124-132.
13. Musa A., Lehrach H., Russo V.A. Distinct expression patterns of two zebrafish homologues of the human APP gene during embryonic development. Dev. Genes Evol. 2001, 211:563-567.
14. Joshi P., Liang J.O., DiMonte K., Sullivan J., Pimplikar S.W. Amyloid precursor protein is required for convergent-extension movements during zebrafish development. Dev. Biol. 2009, 335:1-11.
15. Newman M., Musgrave I.F., Lardelli M. Alzheimer disease: amyloidogenesis, the presenilins and animal models. Biochim. Biophys. Acta 2007, 1772:285-297.
16. Geling A., Steiner H., Willem M., Bally-Cuif L., Haass C. A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO Rep. 2002, 3:688-694.
17. Campbell W.A., Yang H., Zetterberg H., Baulac S., Sears J.A., Liu T., Wong S.T., Zhong T.P., Xia W. Zebrafish lacking Alzheimer presenilin enhancer 2 (Pen-2) demonstrate excessive p53-dependent apoptosis and neuronal loss. J. Neurochem. 2006, 96:1423-1440.
18. Tomasiewicz H.G., Flaherty D.B., Soria J.P., Wood J.G. Transgenic zebrafish model of neurodegeneration. J. Neurosci. Res. 2002, 70:734-745.
19. Paquet D., Bhat R., Sydow A., Mandelkow E.M., Berg S., Hellberg S., Falting J., Distel M., Koster R.W., Schmid B., Haass C. A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation. J. Clin. Invest. 2009, 119:1382-1395.
20. Lee J.A., Cole G.J. Generation of transgenic zebrafish expressing green fluorescent protein under control of zebrafish amyloid precursor protein gene regulatory elements. Zebrafish 2007, 4:277-286.
21. Shakes L.A., Malcolm T.L., Allen K.L., De S., Harewood K.R., Chatterjee P.K. Context dependent function of APPb enhancer identified using enhancer trap-containing BACs as transgenes in zebrafish. Nucleic Acids Res. 2008, 36:6237-6248.
22. Flinn L., Bretaud S., Lo C., Ingham P.W., Bandmann O. Zebrafish as a new animal model for movement disorders. J. Neurochem. 2008, 106:1991-1997.
23. Bretaud S., Lee S., Guo S. Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease. Neurotoxicol. Teratol. 2004, 26:857-864.
24. Lam C.S., Korzh V., Strahle U. Zebrafish embryos are susceptible to the dopaminergic neurotoxin MPTP. Eur. J. Neurosci. 2005, 21:1758-1762.
25. McKinley E.T., Baranowski T.C., Blavo D.O., Cato C., Doan T.N., Rubinstein A.L. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons. Brain Res. Mol. Brain Res. 2005, 141:128-137.
26. Abeliovich A., Flint Beal M. Parkinsonism genes: culprits and clues. J. Neurochem. 2006, 99:1062-1072.
27. Son O.L., Kim H.T., Ji M.H., Yoo K.W., Rhee M., Kim C.H. Cloning and expression analysis of a Parkinson's disease gene, uch-L1, and its promoter in zebrafish. Biochem. Biophys. Res. Commun. 2003, 312:601-607.
28. Bretaud S., Allen C., Ingham P.W., Bandmann O. p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's disease. J. Neurochem. 2007, 100:1626-1635.
29. Flinn L., Mortiboys H., Volkmann K., Koster R.W., Ingham P.W., Bandmann O. Complex I deficiency and dopaminergic neuronal cell loss in Parkin-deficient zebrafish (Danio rerio). Brain 2009, 132:1613-1623.
30. Boehmler W., Petko J., Woll M., Frey C., Thisse B., Thisse C., Canfield V.A., Levenson R. Identification of zebrafish A2 adenosine receptors and expression in developing embryos. Gene Expr. Patterns 2009, 9:144-151.
31. Wen L., Wei W., Gu W., Huang P., Ren X., Zhang Z., Zhu Z., Lin S., Zhang B. Visualization of monoaminergic neurons and neurotoxicity of MPTP in live transgenic zebrafish. Dev. Biol. 2008, 314:84-92.
32. Karlovich C.A., John R.M., Ramirez L., Stainier D.Y., Myers R.M. Characterization of the Huntington's disease (HD) gene homologue in the zebrafish Danio rerio. Gene 1998, 217:117-125.
33. Lumsden A.L., Henshall T.L., Dayan S., Lardelli M.T., Richards R.I. Huntingtin-deficient zebrafish exhibit defects in iron utilization and development. Hum. Mol. Genet. 2007, 16:1905-1920.
34. Diekmann H., Anichtchik O., Fleming A., Futter M., Goldsmith P., Roach A., Rubinsztein D.C. Decreased BDNF levels are a major contributor to the embryonic phenotype of huntingtin knockdown zebrafish. J. Neurosci. 2009, 29:1343-1349.
35. Schiffer N.W., Broadley S.A., Hirschberger T., Tavan P., Kretzschmar H.A., Giese A., Haass C., Hartl F.U., Schmid B. Identification of anti-prion compounds as efficient inhibitors of polyglutamine protein aggregation in a zebrafish model. J. Biol. Chem. 2007, 282:9195-9203.
36. Miller V.M., Nelson R.F., Gouvion C.M., Williams A., Rodriguez-Lebron E., Harper S.Q., Davidson B.L., Rebagliati M.R., Paulson H.L. CHIP suppresses polyglutamine aggregation and toxicity in vitro and in vivo. J. Neurosci. 2005, 25:9152-9161.
37. Williams A., Sarkar S., Cuddon P., Ttofi E.K., Saiki S., Siddiqi F.H., Jahreiss L., Fleming A., Pask D., Goldsmith P., O'Kane C.J., Floto R.A., Rubinsztein D.C. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat. Chem. Biol. 2008, 4:295-305.
38. Baraban S.C. Emerging epilepsy models: insights from mice, flies, worms and fish. Curr. Opin. Neurol. 2007, 20:164-168.
39. Tiedeken J.A., Ramsdell J.S. DDT exposure of zebrafish embryos enhances seizure susceptibility: relationship to fetal p,p′-DDE burden and domoic acid exposure of California sea lions. Environ. Health Perspect. 2009, 117:68-73.
40. Baraban S.C., Taylor M.R., Castro P.A., Baier H. Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience 2005, 131:759-768.
41. Tiedeken J.A., Ramsdell J.S. Embryonic exposure to domoic acid increases the susceptibility of zebrafish larvae to the chemical convulsant pentylenetetrazole. Environ. Health Perspect. 2007, 115:1547-1552.
42. Tiedeken J.A., Ramsdell J.S., Ramsdell A.F. Developmental toxicity of domoic acid in zebrafish (Danio rerio). Neurotoxicol. Teratol. 2005, 27:711-717.
43. Baraban S.C., Dinday M.T., Castro P.A., Chege S., Guyenet S., Taylor M.R. A large-scale mutagenesis screen to identify seizure-resistant zebrafish. Epilepsia 2007, 48:1151-1157.
44. Winter M.J., Redfern W.S., Hayfield A.J., Owen S.F., Valentin J.P., Hutchinson T.H. Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs. J. Pharmacol. Toxicol. Methods 2008, 57:176-187.
45. Bassuk A.G., Wallace R.H., Buhr A., Buller A.R., Afawi Z., Shimojo M., Miyata S., Chen S., Gonzalez-Alegre P., Griesbach H.L., Wu S., Nashelsky M., Vladar E.K., Antic D., Ferguson P.J., Cirak S., Voit T., Scott M.P., Axelrod J.D., Gurnett C., Daoud A.S., Kivity S., Neufeld M.Y., Mazarib A., Straussberg R., Walid S., Korczyn A.D., Slusarski D.C., Berkovic S.F., El-Shanti H.I. A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome. Am. J. Hum. Genet. 2008, 83:572-581.
46. Saba T.G., Montpetit A., Verner A., Rioux P., Hudson T.J., Drouin R., Drouin C.A. An atypical form of erythrokeratodermia variabilis maps to chromosome 7q22. Hum. Genet. 2005, 116:167-171.
47. Montpetit A., Cote S., Brustein E., Drouin C.A., Lapointe L., Boudreau M., Meloche C., Drouin R., Hudson T.J., Drapeau P., Cossette P. Disruption of AP1S1, causing a novel neurocutaneous syndrome, perturbs development of the skin and spinal cord. PLoS Genet. 2008, 4:e1000296.
48. Bonifacino J.S., Glick B.S. The mechanisms of vesicle budding and fusion. Cell 2004, 116:153-166.
49. Robinson M.S. Adaptable adaptors for coated vesicles. Trends Cell Biol. 2004, 14:167-174.
50. Boehm M., Bonifacino J.S. Adaptins: the final recount. Mol. Biol. Cell 2001, 12:2907-2920.
51. Owen D.J., Collins B.M., Evans P.R. Adaptors for clathrin coats: structure and function. Annu. Rev. Cell Dev. Biol. 2004, 20:153-191.
52. Beattie C.E., Carrel T.L., McWhorter M.L. Fishing for a mechanism: using zebrafish to understand spinal muscular atrophy. J. Child Neurol. 2007, 22:995-1003.
53. Drapeau P., Saint-Amant L., Buss R.R., Chong M., McDearmid J.R., Brustein E. Development of the locomotor network in zebrafish. Prog. Neurobiol. 2002, 68:85-111.
54. Lemmens R., Van Hoecke A., Hersmus N., Geelen V., D'Hollander I., Thijs V., Van Den Bosch L., Carmeliet P., Robberecht W. Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish. Hum. Mol. Genet. 2007, 16:2359-2365.
55. Gros-Louis F., Kriz J., Kabashi E., McDearmid J., Millecamps S., Urushitani M., Lin L., Dion P., Zhu Q., Drapeau P., Julien J.P., Rouleau G.A. Als2 mRNA splicing variants detected in KO mice rescue severe motor dysfunction phenotype in Als2 knock-down zebrafish. Hum. Mol. Genet. 2008, 17:2691-2702.
56. Simpson C.L., Lemmens R., Miskiewicz K., Broom W.J., Hansen V.K., van Vught P.W., Landers J.E., Sapp P., Van Den Bosch L., Knight J., Neale B.M., Turner M.R., Veldink J.H., Ophoff R.A., Tripathi V.B., Beleza A., Shah M.N., Proitsi P., Van Hoecke A., Carmeliet P., Horvitz H.R., Leigh P.N., Shaw C.E., van den Berg L.H., Sham P.C., Powell J.F., Verstreken P., Brown R.H., Robberecht W., Al-Chalabi A. Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration. Hum. Mol. Genet. 2009, 18:472-481.
57. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
58. Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Vande Velde C., Bouchard J.P., Lacomblez L., Pochigaeva K., Salachas F., Pradat P.F., Camu W., Meininger V., Dupre N., Rouleau G.A. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008, 40:572-574.
59. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., Baralle F., de Belleroche J., Mitchell J.D., Leigh P.N., Al-Chalabi A., Miller C.C., Nicholson G., Shaw C.E. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008, 319:1668-1672.
60. Hadano S., Benn S.C., Kakuta S., Otomo A., Sudo K., Kunita R., Suzuki-Utsunomiya K., Mizumura H., Shefner J.M., Cox G.A., Iwakura Y., Brown R.H., Ikeda J.E. Mice deficient in the Rab5 guanine nucleotide exchange factor ALS2/alsin exhibit age-dependent neurological deficits and altered endosome trafficking. Hum. Mol. Genet. 2006, 15:233-250.
61. Salinas S., Proukakis C., Crosby A., Warner T.T. Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol. 2008, 7:1127-1138.
62. Valdmanis P.N., Meijer I.A., Reynolds A., Lei A., MacLeod P., Schlesinger D., Zatz M., Reid E., Dion P.A., Drapeau P., Rouleau G.A. Mutations in the KIAA0196 gene at the SPG8 locus cause hereditary spastic paraplegia. Am. J. Hum. Genet. 2007, 80:152-161.
63. Lin P., Li J., Liu Q., Mao F., Qiu R., Hu H., Song Y., Yang Y., Gao G., Yan C., Yang W., Shao C., Gong Y. A missense mutation in SLC33A1, which encodes the acetyl-CoA transporter, causes autosomal-dominant spastic paraplegia (SPG42). Am. J. Hum. Genet. 2008, 83:752-759.
64. Wood J.D., Landers J.A., Bingley M., McDermott C.J., Thomas-McArthur V., Gleadall L.J., Shaw P.J., Cunliffe V.T. The microtubule-severing protein Spastin is essential for axon outgrowth in the zebrafish embryo. Hum. Mol. Genet. 2006, 15:2763-2771.
65. McWhorter M.L., Monani U.R., Burghes A.H., Beattie C.E. Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J. Cell Biol. 2003, 162:919-931.
66. Carrel T.L., McWhorter M.L., Workman E., Zhang H., Wolstencroft E.C., Lorson C., Bassell G.J., Burghes A.H., Beattie C.E. Survival motor neuron function in motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis. J. Neurosci. 2006, 26:11014-11022.
67. Oprea G.E., Krober S., McWhorter M.L., Rossoll W., Muller S., Krawczak M., Bassell G.J., Beattie C.E., Wirth B. Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science 2008, 320:524-527.
68. Boon K.L., Xiao S., McWhorter M.L., Donn T., Wolf-Saxon E., Bohnsack M.T., Moens C.B., Beattie C.E. Zebrafish survival motor neuron mutants exhibit presynaptic neuromuscular junction defects. Hum. Mol. Genet. 2009, 18:3615-3625.
69. Tropepe V., Sive H.L. Can zebrafish be used as a model to study the neurodevelopmental causes of autism?. Genes Brain Behav. 2003, 2:268-281.
70. Wood J.D., Bonath F., Kumar S., Ross C.A., Cunliffe V.T. Disrupted-in-schizophrenia 1 and neuregulin 1 are required for the specification of oligodendrocytes and neurones in the zebrafish brain. Hum. Mol. Genet. 2009, 18:391-404.
71. Elsen G.E., Choi L.Y., Prince V.E., Ho R.K. The autism susceptibility gene met regulates zebrafish cerebellar development and facial motor neuron migration. Dev. Biol. 2009, 335:78-92.
72. Laumonnier F., Cuthbert P.C., Grant S.G. The role of neuronal complexes in human X-linked brain diseases. Am. J. Hum. Genet. 2007, 80:205-220.
73. Skuse D.H. Imprinting, the X-chromosome, and the male brain: explaining sex differences in the liability to autism. Pediatr. Res. 2000, 47:9-16.
74. Grant S.G., Marshall M.C., Page K.L., Cumiskey M.A., Armstrong J.D. Synapse proteomics of multiprotein complexes: en route from genes to nervous system diseases. Hum. Mol. Genet. 2005, 14(Spec No. 2):R225-R234.
75. Gauthier J., Spiegelman D., Piton A., Lafreniere R.G., Laurent S., St-Onge J., Lapointe L., Hamdan F.F., Cossette P., Mottron L., Fombonne E., Joober R., Marineau C., Drapeau P., Rouleau G.A. Novel de novo SHANK3 mutation in autistic patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150B:421-424.
76. Durand C.M., Betancur C., Boeckers T.M., Bockmann J., Chaste P., Fauchereau F., Nygren G., Rastam M., Gillberg I.C., Anckarsater H., Sponheim E., Goubran-Botros H., Delorme R., Chabane N., Mouren-Simeoni M.C., de Mas P., Bieth E., Roge B., Heron D., Burglen L., Gillberg C., Leboyer M., Bourgeron T. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 2007, 39:25-27.
77. Roussignol G., Ango F., Romorini S., Tu J.C., Sala C., Worley P.F., Bockaert J., Fagni L. Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons. J. Neurosci. 2005, 25:3560-3570.
78. Piton A., Michaud J.L., Peng H., Aradhya S., Gauthier J., Mottron L., Champagne N., Lafreniere R.G., Hamdan F.F., Joober R., Fombonne E., Marineau C., Cossette P., Dube M.P., Haghighi P., Drapeau P., Barker P.A., Carbonetto S., Rouleau G.A. Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum. Mol. Genet. 2008, 17:3965-3974.
79. Bahi N., Friocourt G., Carrie A., Graham M.E., Weiss J.L., Chafey P., Fauchereau F., Burgoyne R.D., Chelly J. IL1 receptor accessory protein like, a protein involved in X-linked mental retardation, interacts with Neuronal Calcium Sensor-1 and regulates exocytosis. Hum. Mol. Genet. 2003, 12:1415-1425.
80. 2+-channel and neurite elongation. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:9063-9068.
81. Gambino F., Kneib M., Pavlowsky A., Skala H., Heitz S., Vitale N., Poulain B., Khelfaoui M., Chelly J., Billuart P., Humeau Y. IL1RAPL1 controls inhibitory networks during cerebellar development in mice. Eur. J. Neurosci. 2009, 30:1476-1486.
82. Tabolacci E., Pomponi M.G., Pietrobono R., Terracciano A., Chiurazzi P., Neri G. A truncating mutation in the IL1RAPL1 gene is responsible for X-linked mental retardation in the MRX21 family. Am. J. Med. Genet. 2006, 140:482-487.
83. Carrie A., Jun L., Bienvenu T., Vinet M.C., McDonell N., Couvert P., Zemni R., Cardona A., Van Buggenhout G., Frints S., Hamel B., Moraine C., Ropers H.H., Strom T., Howell G.R., Whittaker A., Ross M.T., Kahn A., Fryns J.P., Beldjord C., Marynen P., Chelly J. A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat. Genet. 1999, 23:25-31.
84. Yoshida T., Mishina M. Zebrafish orthologue of mental retardation protein IL1RAPL1 regulates presynaptic differentiation. Mol. Cell. Neurosci. 2008, 39:218-228.
85. Szatmari P., Paterson A.D., Zwaigenbaum L., Roberts W., Brian J., Liu X.Q., Vincent J.B., Skaug J.L., Thompson A.P., Senman L., Feuk L., Qian C., Bryson S.E., Jones M.B., Marshall C.R., Scherer S.W., Vieland V.J., Bartlett C., Mangin L.V., Goedken R., Segre A., Pericak-Vance M.A., Cuccaro M.L., Gilbert J.R., Wright H.H., Abramson R.K., Betancur C., Bourgeron T., Gillberg C., Leboyer M., Buxbaum J.D., Davis K.L., Hollander E., Silverman J.M., Hallmayer J., Lotspeich L., Sutcliffe J.S., Haines J.L., Folstein S.E., Piven J., Wassink T.H., Sheffield V., Geschwind D.H., Bucan M., Brown W.T., Cantor R.M., Constantino J.N., Gilliam T.C., Herbert M., Lajonchere C., Ledbetter D.H., Lese-Martin C., Miller J., Nelson S., Samango-Sprouse C.A., Spence S., State M., Tanzi R.E., Coon H., Dawson G., Devlin B., Estes A., Flodman P., Klei L., McMahon W.M., Minshew N., Munson J., Korvatska E., Rodier P.M., Schellenberg G.D., Smith M., Spence M.A., Stodgell C., Tepper P.G., Wijsman E.M., Yu C.E., Roge B., Mantoulan C., Wittemeyer K., Poustka A., Felder B., Klauck S.M., Schuster C., Poustka F., Bolte S., Feineis-Matthews S., Herbrecht E., Schmotzer G., Tsiantis J., Papanikolaou K., Maestrini E., Bacchelli E., Blasi F., Carone S., Toma C., Van Engeland H., de Jonge M., Kemner C., Koop F., Langemeijer M., Hijmans C., Staal W.G., Baird G., Bolton P.F., Rutter M.L., Weisblatt E., Green J., Aldred C., Wilkinson J.A., Pickles A., Le Couteur A., Berney T., McConachie H., Bailey A.J., Francis K., Honeyman G., Hutchinson A., Parr J.R., Wallace S., Monaco A.P., Barnby G., Kobayashi K., Lamb J.A., Sousa I., Sykes N., Cook E.H., Guter S.J., Leventhal B.L., Salt J., Lord C., Corsello C., Hus V., Weeks D.E., Volkmar F., Tauber M., Fombonne E., Shih A., Meyer K.J. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet. 2007, 39:319-328.
86. Kim H.G., Kishikawa S., Higgins A.W., Seong I.S., Donovan D.J., Shen Y., Lally E., Weiss L.A., Najm J., Kutsche K., Descartes M., Holt L., Braddock S., Troxell R., Kaplan L., Volkmar F., Klin A., Tsatsanis K., Harris D.J., Noens I., Pauls D.L., Daly M.J., MacDonald M.E., Morton C.C., Quade B.J., Gusella J.F. Disruption of neurexin 1 associated with autism spectrum disorder. Am. J. Hum. Genet. 2008, 82:199-207.
87. Kirov G., Gumus D., Chen W., Norton N., Georgieva L., Sari M., O'Donovan M.C., Erdogan F., Owen M.J., Ropers H.H., Ullmann R. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum. Mol. Genet. 2008, 17:458-465.
88. Rujescu D., Ingason A., Cichon S., Pietilainen O.P., Barnes M.R., Toulopoulou T., Picchioni M., Vassos E., Ettinger U., Bramon E., Murray R., Ruggeri M., Tosato S., Bonetto C., Steinberg S., Sigurdsson E., Sigmundsson T., Petursson H., Gylfason A., Olason P.I., Hardarsson G., Jonsdottir G.A., Gustafsson O., Fossdal R., Giegling I., Moller H.J., Hartmann A.M., Hoffmann P., Crombie C., Fraser G., Walker N., Lonnqvist J., Suvisaari J., Tuulio-Henriksson A., Djurovic S., Melle I., Andreassen O.A., Hansen T., Werge T., Kiemeney L.A., Franke B., Veltman J., Buizer-Voskamp J.E., Sabatti C., Ophoff R.A., Rietschel M., Nothen M.M., Stefansson K., Peltonen L., St Clair D., Stefansson H., Collier D.A. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum. Mol. Genet. 2009, 18:988-996.
89. Rissone A., Monopoli M., Beltrame M., Bussolino F., Cotelli F., Arese M. Comparative genome analysis of the neurexin gene family in Danio rerio: insights into their functions and evolution. Mol. Biol. Evol. 2007, 24:236-252.
90. Setou M., Nakagawa T., Seog D.H., Hirokawa N. Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. Science (New York, N.Y.) 2000, 288:1796-1802.
91. Guillaud L., Setou M., Hirokawa N. KIF17 dynamics and regulation of NR2B trafficking in hippocampal neurons. J. Neurosci. 2003, 23:131-140.
92. Chu P.J., Rivera J.F., Arnold D.B. A role for Kif17 in transport of Kv4.2. J. Biol. Chem. 2006, 281:365-373.
93. Wong R.W., Setou M., Teng J., Takei Y., Hirokawa N. Overexpression of motor protein KIF17 enhances spatial and working memory in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:14500-14505.
94. Roberson R., Toso L., Abebe D., Spong C.Y. Altered expression of KIF17, a kinesin motor protein associated with NR2B trafficking, may mediate learning deficits in a Down syndrome mouse model. Am. J. Obstet. Gynecol. 2008, 198:313. e311-314.
95. Guillaud L., Wong R., Hirokawa N. Disruption of KIF17-Mint1 interaction by CaMKII-dependent phosphorylation: a molecular model of kinesin-cargo release. Nat. Cell Biol. 2008, 10:19-29.
96. Insinna C., Pathak N., Perkins B., Drummond I., Besharse J.C. The homodimeric kinesin, Kif17, is essential for vertebrate photoreceptor sensory outer segment development. Dev. Biol. 2008, 316:160-170.
97. Suster M.L., Kikuta H., Urasaki A., Asakawa K., Kawakami K. Transgenesis in zebrafish with the tol2 transposon system. Methods Mol. Biol. 2009, 561:41-63.
98. Goldman D., Hankin M., Li Z., Dai X., Ding J. Transgenic zebrafish for studying nervous system development and regeneration. Transgenic Res. 2001, 10:21-33.
99. Jessell T.M. Neuronal specification in the spinal cord: inductive signals and transcriptional codes. Nat. Rev. Genet. 2000, 1:20-29.
100. Nakano T., Windrem M., Zappavigna V., Goldman S.A. Identification of a conserved 125 base-pair Hb9 enhancer that specifies gene expression to spinal motor neurons. Dev. Biol. 2005, 283:474-485.
101. Higashijima S., Hotta Y., Okamoto H. Visualization of cranial motor neurons in live transgenic zebrafish expressing green fluorescent protein under the control of the islet-1 promoter/enhancer. J. Neurosci. 2000, 20:206-218.
102. Suster M.L., Kania A., Liao M., Asakawa K., Charron F., Kawakami K., Drapeau P. A novel conserved evx1 enhancer links spinal interneuron morphology and cis-regulation from fish to mammals. Dev. Biol. 2009, 325:422-433.
103. Picker A., Scholpp S., Bohli H., Takeda H., Brand M. A novel positive transcriptional feedback loop in midbrain-hindbrain boundary development is revealed through analysis of the zebrafish pax2.1 promoter in transgenic lines. Development 2002, 129:3227-3239.
104. McLean D.L., Fan J., Higashijima S., Hale M.E., Fetcho J.R. A topographic map of recruitment in spinal cord. Nature 2007, 446:71-75.
105. Kimura Y., Okamura Y., Higashijima S. alx, a zebrafish homolog of Chx10, marks ipsilateral descending excitatory interneurons that participate in the regulation of spinal locomotor circuits. J. Neurosci. 2006, 26:5684-5697.
106. Blader P., Plessy C., Strahle U. Multiple regulatory elements with spatially and temporally distinct activities control neurogenin1 expression in primary neurons of the zebrafish embryo. Mech. Dev. 2003, 120:211-218.
107. Ng A.N., de Jong-Curtain T.A., Mawdsley D.J., White S.J., Shin J., Appel B., Dong P.D., Stainier D.Y., Heath J.K. Formation of the digestive system in zebrafish: III. Intestinal epithelium morphogenesis. Dev. Biol. 2005, 286:114-135.
108. Shin J., Park H.C., Topczewska J.M., Mawdsley D.J., Appel B. Neural cell fate analysis in zebrafish using olig2 BAC transgenics. Methods Cell Sci. 2003, 25:7-14.
109. Kirby B.B., Takada N., Latimer A.J., Shin J., Carney T.J., Kelsh R.N., Appel B. In vivo time-lapse imaging shows dynamic oligodendrocyte progenitor behavior during zebrafish development. Nat. Neurosci. 2006, 9:1506-1511.
110. Bayer T.A., Campos-Ortega J.A. A transgene containing lacZ is expressed in primary sensory neurons in zebrafish. Development (Cambridge, England) 1992, 115:421-426.
111. Halpern M.E., Rhee J., Goll M.G., Akitake C.M., Parsons M., Leach S.D. Gal4/UAS transgenic tools and their application to zebrafish. Zebrafish 2008, 5:97-110.
112. Dong J., Stuart G.W. Transgene manipulation in zebrafish by using recombinases. Methods Cell Biol. 2004, 77:363-379.
113. Provost E., Rhee J., Leach S.D. Viral 2A peptides allow expression of multiple proteins from a single ORF in transgenic zebrafish embryos. Genesis 2007, 45:625-629.
114. Moens C.B., Donn T.M., Wolf-Saxon E.R., Ma T.P. Reverse genetics in zebrafish by TILLING. Brief. Funct. Genomic Proteomic 2008, 7:454-459.
115. Foley J.E., Yeh J.R., Maeder M.L., Reyon D., Sander J.D., Peterson R.T., Joung J.K. Rapid mutation of endogenous zebrafish genes using zinc finger nucleases made by Oligomerized Pool ENgineering (OPEN). PLoS One 2009, 4:e4348.
116. Woods I.G., Schier A.F. Targeted mutagenesis in zebrafish. Nat. Biotechnol. 2008, 26:650-651.
117. Ouyang X., Shestopalov I.A., Sinha S., Zheng G., Pitt C.L., Li W.H., Olson A.J., Chen J.K. Versatile synthesis and rational design of caged morpholinos. J. Am. Chem. Soc. 2009, 131:13255-13269.
118. Wu S., Storey J.M., Storey K.B. Phosphoglycerate kinase 1 expression responds to freezing, anoxia, and dehydration stresses in the freeze tolerant wood frog, Rana sylvatica. J. Exp. Zool. A Ecol. Genet. Physiol. 2009, 311:57-67.
119. Morcos P.A., Li Y., Jiang S. Vivo-morpholinos: a non-peptide transporter delivers morpholinos into a wide array of mouse tissues. Biotechniques 2008, 45:613-614. 616, 618 passim.
120. Sipe C.W., Saha M.S. The use of microarray technology in nonmammalian vertebrate systems. Methods Mol. Biol. 2007, 382:1-16.
121. Hegde A., Qiu N.C., Qiu X., Ho S.H., Tay K.Q., George J., Ng F.S., Govindarajan K.R., Gong Z., Mathavan S., Jiang Y.J. Genomewide expression analysis in zebrafish mind bomb alleles with pancreas defects of different severity identifies putative Notch responsive genes. PLoS One 2008, 3:e1479.
122. Zon L.I., Peterson R.T. In vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov. 2005, 4:35-44.
123. Yeh J.R., Munson K.M., Elagib K.E., Goldfarb A.N., Sweetser D.A., Peterson R.T. Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation. Nat. Chem. Biol. 2009, 5:236-243.
124. Mukhopadhyay A., Peterson R.T. Deciphering arterial identity through gene expression, genetics, and chemical biology. Curr. Opin. Hematol. 2008, 15:221-227.
125. Kabashi E., Lin L., Tradewell M.L., Dion P.A., Bercier V., Bourgouin P., Rochefort D., Hadj S.B., Durham H.D., Vande Velde C., Rouleau G.A., Drapeau P. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Human Mol. Gen. 2010, 19:671-683.
126. Gauthier J., Champagne N., Lafrenière R.G., Xiong L., Spiegelman D., Brustein E., Lapointe M., Peng H., Côté M., Noreau A., Hamdan F.F., Piton A., Addington A.M., Rapoport J.L., DeLisi L.E., Krebs M.-O., Joober R., Fathalli F., Mouaffak F., Haghighi A.P., Néri C., Dubé M.-P., Samuels M.E., Marineau C., Stone E.A., Awadalla P., Barker P.A., Carbonetto S., Drapeau P., Rouleau G.A. De novo synaptic scaffolding protein SHANK3 mutations in patients ascertained with schizophrenia. Proc. Natl. Acad. Sci. USA 2010, 107:7863-7868. and the S2D team.
127. Tarabeux J., Champagne N., Brustein E., Hamdan F.F., Gauthier J., Lapointe M., Maios C., Piton A., Spiegelman D., Henrion É., S2D team, Mille B., Rapoport J.L., DeLisi L.E., Joober R., Fathalli F., Fombonne É., Mottron L., Forget-Dubois N., Boivin M., Michaud J.L., Lafrenière R.G., Drapeau P., Krebs M.-O., Rouleau G.A. De Novo Truncating Mutation in KIF17 Associated with Schizophrenia. Biol. Psy. 2010, 68:649-656.